Intrathecal clonidine for controlling spastic hypertonia

Physical Medicine and Rehabilitation Clinics of North America

Volumn 12, Issue 4, 2001, Pages 939-951

  Remy Neris O ^a   Denys, P ^a   Bussel, B ^a  

^a Centre J Calve Fondation Hopale   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE;

CLINICAL TRIAL; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG INFUSION; DRUG MECHANISM; HUMAN; LONG TERM CARE; MUSCLE HYPERTONIA; PRIORITY JOURNAL; REVIEW; SPASTICITY;

EID: 0035153816     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1047-9651(18)30040-8     Document Type: Review

References (71)

1. The effect of DOPA on the spinal cord. 1. Influence on transmission from primary afferents
2. Preliminary trial of carisprodol in multiple sclerosis
3. Effect of intrathecal baclofen on the monosynaptic reflex in humans: Evidence for a postsynaptic action
4. The effects of clonidine and yohimbine on locomotion and cutaneous reflexes in the adult chronic spinal cat
5. Clonidine does not impair redistribution hypothermia after the induction of anesthesia
6. The influence of ambient temperature on thermoregulatory responses to intraventricularly injected monoamines in sheep, goats and rabbits
7. Dose related prolongation of hyperbaric tetracaine spinal anesthesia by clonidine in humans
8. Comparison of effects of monoamines on transmission in spinal pathways from group I and II muscle afferents in the cat
9. Comparison of effects of different types of NA and 5 HT agonists on transmission from group II afferents in the cat
10. Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotoninergic drugs
11. Pharmacokinetics and dynamics of intravenous, intrathecal and epidural clonidine in sheep
12. Effects of intrathecal alpha1- and alpha2-noradrenergic agonists and norepinephrine on locomotion in chronic spinal cats
13. Use of clonidine for treatment of spasticity arising from various forms of brain injury: A case series
14. Selective antinociceptive effects of tizanidine (DS 103-382), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord
15. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity
16. Intrathecal clonidine for refractory detrusor hyperreflexia in spinal cord injured patients: A preliminary report
17. Locomotor capacity of spinal cord in paraplegic patients
18. Motor unit involvement in spastic paresis. Relationship between leg muscle activation and histochemistry
19. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia
20. Clonidine effect on spasticity: A clinical trial
21. Alpha 2 adrenoreceptors mediate clonidine induce sedation in the rat
22. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics
23. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose response study
24. An alpha2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones
25. The locomotion of the acute spinal cat injected with clonidine i.v.
26. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients
27. Cerebrospinal fluid kinetics of epidural clonidine in man
28. Co-administration of pethidine and clonidine: A spinal anaesthetic technique for total hip replacement
29. Postoperative analgesia after co-administration of clonidine and morphine by the intrathecal route in patients undergoing hip replacement
30. Contralateral reflex reversal controlled by limb position in the acute spinal cat injected with clonidine i.v.
31. On the central generation of locomotion in the low spinal cat
32. A comparison of the cardiovascular and sedative actions of the alpha adrenoceptor agonists, FLA-136 and clonidine in the rat
33. Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride)
34. Physostigmine prevents postanesthetic shivering as does meperidine or clonidine
35. Interneuronal relay in spinal pathways from proprioceptors
36. Modulation of responses of feline gamma-motoneurones by noradrenaline, tizanidine and clonidine
37. Clonidine in the treatment of spasticity in patients with multiple sclerosis
38. Effects of clonidine on central sympathetic tone
39. Haemodynamic actions of clonidine in tetraplegia - Effects at rest and during urinary bladder stimulation
40. Symposium synopsis
41. Presynaptic regulation of catecholamine release
42. Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients
43. Central effects of clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, St 155) upon thermoregulation in the sheep and goat
44. Nerve endings in mammalian muscle
45. Evidence that secondary as well as the primary endings of the muscle spindles may be responsible for the tonic stretch reflex of the decerebrate cat
46. Early clinical experience with clonidine in spinal spasticity
47. Effect of clonidine on postpartum shivering after epidural analgesia: A randomized, controlled, double-blind study
48. Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: A case study
49. Clonidine in spinal cord injury
50. Reflex changes induced by clonidine in spinal cord injured patients
51. Effects of drugs on walking after spinal cord injury
52. Spasticity and muscle contracture following stroke
53. Modulatory action of noradrenergic system on spinal motoneurons in humans
54. Prolongation of isobaric bupivacaine spinal anesthesia with epinephrine and clonidine for hip surgery
55. Effects of intrathecal clonidine on spinal reflexes and human locomotion in incomplete paraplegic subjects
56. The reflex functions of the completely divided spinal cord in man, compared with those associated with less severe injury
57. Long latency spinal reflex in man after flexor reflex afferent stimulation
58. Clonidine in the treatment of brainstem spasticity. Case report
59. Localisation of the hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapressan)
60. The effect of DOPA and clonidine on reflex pathways from group II muscle afferents to alpha motoneurones in the cat
61. Cardiac slowing effects of clonidine (ST-155) in dogs
62. Sites of central nervous action of clonidine on reflex autonomic function in the unanaesthetized rabbit
63. The pattern of excitation of human lower limb motoneurones by probable group II muscle afferents
64. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine
65. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients
66. Physiological and structural changes in the cat's soleus muscle due to immobilization at different lengths by plaster casts
67. Effect of clonidine on motoneuron excitability in spinalized rats
68. Clinical trial of an alpha adrenergic receptor stimulating drug (clonidine) for treatment of spasticity in spinal cord injured patients
69. Effects of tizanidine (DS 103-282) on dorsal horn convergent neurones in the rat
70. Summary of combined clinical analysis of controlled clinical trials with tizanidine
71. Effect of transdermal clonidine on spinal spasticity. A case series